The AZT fire storm

Gallagher, John
May 1993
Advocate;5/18/93, Issue 629, p29
Reports on the controversy surrounding the effectiveness of AZT in the treatment of AIDS. Article published in a medical journal claiming that the antiviral drug may not slow the onset of AIDS in HIV-infected persons; Reaction of AIDS activists.


Related Articles

  • Combined zidovunine and didanosine prolongs survival in HIV.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p54 

    Presents an abstract of the research report entitled `Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy,' by R.T. Schooley, et al published in the June 1996 issue of the `Journal of Infectious...

  • PHS meeting addresses results of recent AZT study. Anderson, Margaret A. // Nation's Health;Jul94, Vol. 24 Issue 6, p9 

    Focuses on a June 1994 Public Health Service meeting attended by different constituencies in response to findings that zidovudine (AZT) reduced maternal to infant HIV transmission. Role of the National Institutes of Health and the Centers for Disease Control and Prevention in the meeting;...

  • Cruel confusion.  // New Scientist;8/7/93, Vol. 139 Issue 1885, p3 

    Reports on the ongoing confusion over the drug zidovudine (AZT) and its control over the AIDS disease. Concord study showing AZT not delaying the onset of AIDS; Contradictions from study made by Wellcome company; United States tightening recommendations for who should receive zidovudine based...

  • Possible AZT link to cancer.  // AIDS Patient Care & STDs;Jun97, Vol. 11 Issue 3, p195 

    Presents information on studies regarding a link between the drug AZT and the development of cancer. Discussion on each study; Benefits of AZT in late pregnancy.

  • Nevirapine, AZT, and DDI combation in infants and children.  // AIDS Patient Care & STDs;Oct97, Vol. 11 Issue 5, p373 

    Focuses on a study of the use of AZT + ddI + nevirapine drugs in infants and children who are human immunodeficiency virus infected. Reference to a case study; Detailed information on the study; Where information on the study can be obtained..

  • Response: Arguments contradict the 'foreign protein-zidovudine' hypothesis. Sabin, Caroline A.; Phillips, Andrew N. // BMJ: British Medical Journal (International Edition);1/27/96, Vol. 312 Issue 7025, p211 

    Presents arguments that contradict the foreign protein-zidovudine hypothesis by professor Peter Duesberg. Need for long term follow up study to determine seroconversion in patients with HIV; Difference of a lifetime usage of concentrate; Prescribing zidovudine to British hemophilic patients...

  • Three Cheers for the FDA!  // Advocate;10/28/86, Issue 458, p18 

    Reports on the United States Food and Drug Administration's approval of wide-spread distribution of AZT, an anti-AIDS drug. Absence of knowledge of the side effects of AZT.

  • AZT Questions. Helquist, Michael // Advocate;10/28/86, Issue 458, p23 

    Focuses on the decision of the United States Food and Drug Administration to distribute the drug AZT. Limited testing of the drug; Absence of information on the side effects of the drug.

  • Brief Reports. Helquist, Michael // Advocate;1/30/90, Issue 543, p28 

    Presents news briefs concerning AZT in the United States. Recommended dose of AZT; Effectiveness of the bone marrow transplant and use of AZT.

  • NEW AZT STUDY RAISES QUESTIONS--MOSTLY ABOUT ITSELF. Delaney, Martin // Advocate;4/9/91, Issue 574, p33 

    Reports on a study concerning AZT drug conducted by the U.S. Department of Veterans Affairs. Controversy surrounding the study; Factors that confounded analysis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics